Cargando…
Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
Respiratory syncytial virus (RSV) causes a significant proportion of the global burden of respiratory disease. Here we summarize the conclusions of a series of chapters written by investigators describing and interpreting what is known about the virology, clinical manifestations, immunity, pathogene...
Autores principales: | Graham, Barney S., Anderson, Larry J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121045/ https://www.ncbi.nlm.nih.gov/pubmed/24362701 http://dx.doi.org/10.1007/978-3-642-38919-1_20 |
Ejemplares similares
-
Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
por: Simões, Eric A. F., et al.
Publicado: (2015) -
Challenges to Evaluating Respiratory Syncytial Virus Mortality in Bangladesh, 2004–2008
por: Stockman, Lauren J., et al.
Publicado: (2013) -
Strategic priorities for respiratory syncytial virus (RSV) vaccine development
por: Anderson, L.J., et al.
Publicado: (2013) -
Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
por: Biagi, Carlotta, et al.
Publicado: (2020) -
Functional Features of the Respiratory Syncytial Virus G Protein
por: Anderson, Larry J., et al.
Publicado: (2021)